Fig. 1 | Nature Communications

Fig. 1

From: Ebola viral dynamics in nonhuman primates provides insights into virus immuno-pathogenesis and antiviral strategies

Fig. 1The alternative text for this image may have been generated using AI.

Survival and virological data. a Design of the four infected NHP experiments. b Survival curves. c Ebola virus plasma viral load. d Favipiravir plasma concentrations. Dosing regimen groups were untreated (black), 100 mg kg−1 BID (green), 150 mg kg−1 BID (blue), and 180 mg kg−1 BID (red). Gray areas correspond to dosing periods

Back to article page